Equine Therapy for Dementia

Corliss Wallingford was inspired to start a therapeutic horse riding center in her home state of Virginia after her daughter, who is non-verbal, joined a similar program.  For 19 years, Simple Changes Therapeutic Riding Center in Mason Neck, not far from Washington, D.C., has offered what its co-founder describes as “science-backed equine-assisted activities” to people […]

Editing Genes to Beat Alzheimer’s

The underlying cause of Alzheimer’s disease is unknown, but scientists have lots of reason to believe that people’s genetics affect how susceptible they are: Some genes multiply risk, while others appear to be protective. And until recently, scientists didn’t have the tools to add, subtract, or edit genes involved in diseases like Alzheimer’s. That’s changing: […]

Unexpected Symptoms: How To Manage Personality Changes in Dementia

Written by Being Patient Personality changes are not often talked about as a common symptom of dementia, so when these changes start to appear in a friend, care subject or loved one, they can seem abrupt, surprising, and disarming. While new differences in behavior — from sudden anger, irritation, anxiety, to, even, usual sexual behavior […]

What If Your Smartphone Could Detect Cognitive Decline?

Written by Being Patient Detecting Alzheimer’s early is crucial because it allows people to get new treatments, participate in clinical trials, and make positive lifestyle changes. We now know that our voice might be the first thing that changes before any other symptoms. And so voice biomarkers, as an early diagnostic tool, might be coming […]

Do Statins Cause Dementia?

Written by Being Patient About one in four Americans over 40 take drugs called statins, which lower levels of cholesterol, to help prevent cardiovascular disease. You might recognize some of these drug names if you or someone you know has high cholesterol: Lipitor, Lescol XL, Altoprev, Livalo… These statins prevent cholesterol build-up in blood vessels […]

3 Reasons Black Americans Have Higher Dementia Risk

Written by Being Patient Experts estimate that, by 2030, more than 8 million Americans will be living with Alzheimer’s disease or another form of dementia. Black Americans will make up a disproportionate amount of these cases: They are twice as likely to develop these diseases than their white counterparts. Despite ongoing research, scientists still can’t […]

Are We Flushing Away the First Signs of Alzheimer’s?

Written by Being Patient There are a few new drugs out there that can actually slow down Alzheimer’s disease. But, by the time around half of Americans get their diagnosis, it’s too late to intervene. Scientists hope a simple new kind of test could make it possible to catch Alzheimer’s while there’s still time to […]

Summer Travel: How to Plan a Vacation Around Dementia

Written by Being Patient Just because your loved one has dementia doesn’t mean you have to stop taking trips or vacations together. While it may make travel more daunting, research supports the benefits of outdoor activity for people living with dementia — and experts are offering guidelines to make planning an outdoor vacation manageable, safe, and […]

News

/*! elementor – v3.21.0 – 26-05-2024 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=”.svg”]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} /*! elementor – v3.21.0 – 26-05-2024 */ .elementor-heading-title{padding:0;margin:0;line-height:1}.elementor-widget-heading .elementor-heading-title[class*=elementor-size-]>a{color:inherit;font-size:inherit;line-height:inherit}.elementor-widget-heading .elementor-heading-title.elementor-size-small{font-size:15px}.elementor-widget-heading .elementor-heading-title.elementor-size-medium{font-size:19px}.elementor-widget-heading .elementor-heading-title.elementor-size-large{font-size:29px}.elementor-widget-heading .elementor-heading-title.elementor-size-xl{font-size:39px}.elementor-widget-heading .elementor-heading-title.elementor-size-xxl{font-size:59px} K2 Newsletter We love to keep you in the loop on what is going on Alzheimer’s disease research and our latest studies.  Here are the latest e-newsletters that have […]

K2 Medical Research Join Forces with Magruder Eye Institute to Advance Alzheimer’s Clinical Trial Accessibility Through RetiSpec’s AI-Driven Eye Test

ORLANDO, December 30, 2023 – K2 Medical Research, a privately-owned clinical research facility in the greater Orlando area, has teamed up with Magruder Eye Institute and RetiSpec in a research pilot to enhance access to clinical trials. This groundbreaking collaboration aims to study how leveraging RetiSpec’s cutting-edge AI technology as a trial pre-screening tool at […]

News

/*! elementor – v3.18.0 – 08-12-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=”.svg”]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} /*! elementor – v3.18.0 – 08-12-2023 */ .elementor-heading-title{padding:0;margin:0;line-height:1}.elementor-widget-heading .elementor-heading-title[class*=elementor-size-]>a{color:inherit;font-size:inherit;line-height:inherit}.elementor-widget-heading .elementor-heading-title.elementor-size-small{font-size:15px}.elementor-widget-heading .elementor-heading-title.elementor-size-medium{font-size:19px}.elementor-widget-heading .elementor-heading-title.elementor-size-large{font-size:29px}.elementor-widget-heading .elementor-heading-title.elementor-size-xl{font-size:39px}.elementor-widget-heading .elementor-heading-title.elementor-size-xxl{font-size:59px} K2 Newsletter We love to keep you in the loop on what is going on Alzheimer’s disease research and our latest studies.  Here are the latest e-newsletters that have […]

News

/*! elementor – v3.21.0 – 26-05-2024 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=”.svg”]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} /*! elementor – v3.21.0 – 26-05-2024 */ .elementor-heading-title{padding:0;margin:0;line-height:1}.elementor-widget-heading .elementor-heading-title[class*=elementor-size-]>a{color:inherit;font-size:inherit;line-height:inherit}.elementor-widget-heading .elementor-heading-title.elementor-size-small{font-size:15px}.elementor-widget-heading .elementor-heading-title.elementor-size-medium{font-size:19px}.elementor-widget-heading .elementor-heading-title.elementor-size-large{font-size:29px}.elementor-widget-heading .elementor-heading-title.elementor-size-xl{font-size:39px}.elementor-widget-heading .elementor-heading-title.elementor-size-xxl{font-size:59px} K2 Newsletter We love to keep you in the loop on what is going on Alzheimer’s disease research and our latest studies.  Here are the latest e-newsletters that have […]

News

/*! elementor – v3.21.0 – 26-05-2024 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=”.svg”]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} /*! elementor – v3.21.0 – 26-05-2024 */ .elementor-heading-title{padding:0;margin:0;line-height:1}.elementor-widget-heading .elementor-heading-title[class*=elementor-size-]>a{color:inherit;font-size:inherit;line-height:inherit}.elementor-widget-heading .elementor-heading-title.elementor-size-small{font-size:15px}.elementor-widget-heading .elementor-heading-title.elementor-size-medium{font-size:19px}.elementor-widget-heading .elementor-heading-title.elementor-size-large{font-size:29px}.elementor-widget-heading .elementor-heading-title.elementor-size-xl{font-size:39px}.elementor-widget-heading .elementor-heading-title.elementor-size-xxl{font-size:59px} K2 Newsletter We love to keep you in the loop on what is going on Alzheimer’s disease research and our latest studies.  Here are the latest e-newsletters that have […]

News

/*! elementor – v3.21.0 – 26-05-2024 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=”.svg”]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} /*! elementor – v3.21.0 – 26-05-2024 */ .elementor-heading-title{padding:0;margin:0;line-height:1}.elementor-widget-heading .elementor-heading-title[class*=elementor-size-]>a{color:inherit;font-size:inherit;line-height:inherit}.elementor-widget-heading .elementor-heading-title.elementor-size-small{font-size:15px}.elementor-widget-heading .elementor-heading-title.elementor-size-medium{font-size:19px}.elementor-widget-heading .elementor-heading-title.elementor-size-large{font-size:29px}.elementor-widget-heading .elementor-heading-title.elementor-size-xl{font-size:39px}.elementor-widget-heading .elementor-heading-title.elementor-size-xxl{font-size:59px} K2 Newsletter We love to keep you in the loop on what is going on Alzheimer’s disease research and our latest studies.  Here are the latest e-newsletters that have […]

News

/*! elementor – v3.21.0 – 26-05-2024 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=”.svg”]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} /*! elementor – v3.21.0 – 26-05-2024 */ .elementor-heading-title{padding:0;margin:0;line-height:1}.elementor-widget-heading .elementor-heading-title[class*=elementor-size-]>a{color:inherit;font-size:inherit;line-height:inherit}.elementor-widget-heading .elementor-heading-title.elementor-size-small{font-size:15px}.elementor-widget-heading .elementor-heading-title.elementor-size-medium{font-size:19px}.elementor-widget-heading .elementor-heading-title.elementor-size-large{font-size:29px}.elementor-widget-heading .elementor-heading-title.elementor-size-xl{font-size:39px}.elementor-widget-heading .elementor-heading-title.elementor-size-xxl{font-size:59px} K2 Newsletter We love to keep you in the loop on what is going on Alzheimer’s disease research and our latest studies.  Here are the latest e-newsletters that have […]

News

/*! elementor – v3.21.0 – 26-05-2024 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=”.svg”]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} /*! elementor – v3.21.0 – 26-05-2024 */ .elementor-heading-title{padding:0;margin:0;line-height:1}.elementor-widget-heading .elementor-heading-title[class*=elementor-size-]>a{color:inherit;font-size:inherit;line-height:inherit}.elementor-widget-heading .elementor-heading-title.elementor-size-small{font-size:15px}.elementor-widget-heading .elementor-heading-title.elementor-size-medium{font-size:19px}.elementor-widget-heading .elementor-heading-title.elementor-size-large{font-size:29px}.elementor-widget-heading .elementor-heading-title.elementor-size-xl{font-size:39px}.elementor-widget-heading .elementor-heading-title.elementor-size-xxl{font-size:59px} K2 Newsletter We love to keep you in the loop on what is going on Alzheimer’s disease research and our latest studies.  Here are the latest e-newsletters that have […]

News

/*! elementor – v3.21.0 – 26-05-2024 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=”.svg”]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} /*! elementor – v3.21.0 – 26-05-2024 */ .elementor-heading-title{padding:0;margin:0;line-height:1}.elementor-widget-heading .elementor-heading-title[class*=elementor-size-]>a{color:inherit;font-size:inherit;line-height:inherit}.elementor-widget-heading .elementor-heading-title.elementor-size-small{font-size:15px}.elementor-widget-heading .elementor-heading-title.elementor-size-medium{font-size:19px}.elementor-widget-heading .elementor-heading-title.elementor-size-large{font-size:29px}.elementor-widget-heading .elementor-heading-title.elementor-size-xl{font-size:39px}.elementor-widget-heading .elementor-heading-title.elementor-size-xxl{font-size:59px} K2 Newsletter We love to keep you in the loop on what is going on Alzheimer’s disease research and our latest studies.  Here are the latest e-newsletters that have […]

News

/*! elementor – v3.21.0 – 26-05-2024 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=”.svg”]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} /*! elementor – v3.21.0 – 26-05-2024 */ .elementor-heading-title{padding:0;margin:0;line-height:1}.elementor-widget-heading .elementor-heading-title[class*=elementor-size-]>a{color:inherit;font-size:inherit;line-height:inherit}.elementor-widget-heading .elementor-heading-title.elementor-size-small{font-size:15px}.elementor-widget-heading .elementor-heading-title.elementor-size-medium{font-size:19px}.elementor-widget-heading .elementor-heading-title.elementor-size-large{font-size:29px}.elementor-widget-heading .elementor-heading-title.elementor-size-xl{font-size:39px}.elementor-widget-heading .elementor-heading-title.elementor-size-xxl{font-size:59px} K2 Newsletter We love to keep you in the loop on what is going on Alzheimer’s disease research and our latest studies.  Here are the latest e-newsletters that have […]

Join a Study

If you are interested in learning more or participating in any of our studies, please fill out the form below and our office will get back to you within 1-2 business days. 

*By signing up you agree to be contacted about clinical research studies by our company, its affiliates or partners. Typical methods of contact include phone calls, text messages, pre-recorded messages, emails, automated technology or postal mail. This includes if the number is currently on any Do Not Call Lists. As we contact you, your electronic record will be updated accordingly with current relevant health information. This consent is not required to participate in a clinical research study.

K2 is Closed for the holidays

All K2 locations will be closed from December 24, 2024 – January 5, 2025.  We will reopen on January 6, 2025.  In the meantime, please check out our website to learn more about our clinical research trials, our teams, and ways you can join our growing team.  

Wishing you and your families a Happy Holiday Season! 

Melissa Belardo, APRN

Clinical Investigator

Melissa Belardo, is a certified family nurse practitioner (FNP-BC), joins K2 Medical Research with more than a decade of clinical experience. She has served as an investigator in over 20 trials. Prior to clinical research, she held roles in gastroenterology, hepatology, and nurse education.

Melissa’s academic background includes a Bachelor of Science in Nursing from Adventist University, followed by a master’s degree in Family Nurse Practitioner from Georgetown University.

Melissa is a native of the US Virgin Islands’ and is fluent in both English and Spanish; Melissa has lived in central Florida for the past twenty years. When she’s not at work, you can find her volunteering at her local church and spending time with family.